Common mistakes healthtech founders make

Healthtech founders tend to fall into three distinct traps.

The first is over-dependence on a single customer or pilot. When a critical early deal gets stuck or dissolves, founders often collapse emotionally and financially rather than building a diversified customer base [Ep 8]. This is particularly acute in the NHS, where delays happen for reasons beyond anyone's control.

The second is chasing venture capital too early without understanding the actual capital requirements of their model. Many founders assume venture-scale growth is the only path, building capital-intensive strategies that don't match what's needed clinically or commercially [#357]. Related: the temptation to copy and paste a solution across geographies to hit exit multiples, rather than solving the specific problem in front of them [#432].

The third is underestimating the legal and contractual reality of company building. Founders often enter naive about regulatory compliance, payment terms, contract enforcement, and the fact that not everyone operates in good faith [#388]. The surprise here isn't the complexity—it's the assumption that it won't matter.

What ties these together: founders caught between two conflicting worlds. They need evidence-based practicality to sell to clinicians and hospitals, yet venture culture rewards optimism and scale [#273]. The ones who survive recognise the tension and build accordingly, rather than defaulting to one playbook.